Atlas Trials

Atropine and Spectacle Combination Treatment (ASPECT): 12-month Results of a Randomized Clinical Trial for Myopia Control

Clinical trial NCT06431841 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06431841
Sponsor
Hospital San Carlos, Madrid
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Myopia
Start date
2022-02-23
Primary completion
2025-06-30
Enrollment
111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.